2799:HKEXChina CITIC Financial Asset Management Co., Ltd. Class H Analysis
Data as of 2026-03-15 - not real-time
HK$0.78
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
China CITIC Financial Asset Management (2799.HK) is trading at HK$0.78, well below its 20‑day SMA of HK$0.82 and the 200‑day SMA of HK$1.01, indicating a bearish price environment. The MACD histogram is negative and the signal line is bearish, while the RSI sits at 36, suggesting limited upside momentum. Volume has been increasing, yet the stock is hovering just above the identified support at HK$0.77 and well under the resistance of HK$0.89. Despite the technical weakness, the company’s price‑to‑earnings ratio of 5.6 is far cheaper than the industry average of 16.3, and the discounted cash‑flow model values the shares at roughly HK$13.1, implying a potential upside of over 60%. The “Greed” sentiment reading of 72.9 reinforces the market’s appetite for risk‑taking in this undervalued name. Revenue has surged 44% year‑over‑year and profit margins exceed 60%, highlighting strong earnings power. However, the firm carries an extreme debt‑to‑equity ratio above 1,700% and a historic max drawdown of 41%, underscoring balance‑sheet vulnerability.
The company generates robust operating cash flow of HK$61.8 bn, but free cash flow remains zero, reflecting ongoing capital deployment. With a beta of 0.39 the stock is relatively insulated from market swings, yet its 30‑day volatility of 33% signals pronounced price swings. Regulatory scrutiny in China’s financial sector adds a high regulatory risk component, while exposure to the domestic market creates a medium geographic risk. No dividend is paid, making dividend sustainability a non‑factor. Given the deep valuation discount, solid earnings growth, and sizable upside, the medium‑ to long‑term outlook is positive, but short‑term price pressure and balance‑sheet strain advise caution. Investors should therefore monitor the support level and any policy developments closely. Overall, the stock presents a compelling value play with significant upside potential if it can navigate its debt burden and regulatory environment.
The company generates robust operating cash flow of HK$61.8 bn, but free cash flow remains zero, reflecting ongoing capital deployment. With a beta of 0.39 the stock is relatively insulated from market swings, yet its 30‑day volatility of 33% signals pronounced price swings. Regulatory scrutiny in China’s financial sector adds a high regulatory risk component, while exposure to the domestic market creates a medium geographic risk. No dividend is paid, making dividend sustainability a non‑factor. Given the deep valuation discount, solid earnings growth, and sizable upside, the medium‑ to long‑term outlook is positive, but short‑term price pressure and balance‑sheet strain advise caution. Investors should therefore monitor the support level and any policy developments closely. Overall, the stock presents a compelling value play with significant upside potential if it can navigate its debt burden and regulatory environment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical momentum (MACD, RSI, price below SMAs)
- Proximity to support level at HK$0.77
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount (P/E 5.6 vs industry 16.3)
- Strong revenue growth and profit margins
- Large upside implied by DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued with long‑run upside potential
- Robust operating cash flow generation
- Resilient beta indicating low systematic risk
Key Metrics & Analysis
Financial Health
Revenue Growth44.30%
Profit Margin64.40%
P/E Ratio5.6
ROE14.69%
ROA0.75%
Debt/Equity1744.17
P/B Ratio1.4
Op. Cash FlowHK$61.8B
Industry P/E16.4
Technical Analysis
TrendBearish
RSI36.6
SupportHK$0.77
ResistanceHK$0.89
MA 20HK$0.82
MA 50HK$0.84
MA 200HK$1.01
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueHK$13.09
Target PriceHK$1.26
Upside/Downside61.01%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.39
Volatility33.11%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.